Showing results (261-270 of 6,006) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|March 21, 2006
Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemopreventionElisabeth Bertl, Helmut Bartsch, Clarissa Gerhäuser
Molecular Cancer Therapeutics|March 21, 2006
Differential effects of bryostatin 1 and 12-O-tetradecanoylphorbol-13-acetate on the regulation and activation of RasGRP1 in mouse epidermal keratinocytesMatthew C Tuthill, Carolyn E Oki, Patricia S Lorenzo
Molecular Cancer Therapeutics|March 21, 2006
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastomaDimpy Koul, Ruijun Shen, Sherry Bergh, et al.
Molecular Cancer Therapeutics|March 21, 2006
Identification of a small topoisomerase I-binding peptide that has synergistic antitumor activity with 9-aminocamptothecinChristopher D Pond, Kathryn M Marshall, Louis R Barrows
Molecular Cancer Therapeutics|March 21, 2006
Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299)Elvira Crescenzi, Angela Chiaviello, Gianfranco Canti, et al.
Molecular Cancer Therapeutics|December 11, 2007
Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cellsClint Mitchell, Maragret A Park, Guo Zhang, et al.
Molecular Cancer Therapeutics|May 17, 2008
Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitorsHong Su, Lucia Altucci, Qidong You
Molecular Cancer Therapeutics|May 17, 2008
Combi-targeting concept: an optimized single-molecule dual-targeting model for the treatment of chronic myelogenous leukemiaAthanasia Katsoulas, Zakaria Rachid, James P McNamee, et al.
Molecular Cancer Therapeutics|May 17, 2008
Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cellsXia Wang, Wenshu Chen, Weihua Zeng, et al.
Molecular Cancer Therapeutics|May 17, 2008
Relevance of the Fanconi anemia pathway in the response of human cells to trabectedinJosé A Casado, Paula Río, Esther Marco, et al.
Pageof 601